Skip to main content
All lobbying filings

SANDOZ INC

Lobbying for SANDOZ INC · Pharmaceutical company

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$100,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New Jersey

Official filing document

 Government bodies contacted 4
  • Commerce, Dept of (DOC)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Medicare/Medicaid

Advocating to remove non-payer discounts from the ASP calculation for Medicare Part B Promoting a resilient pharmaceutical supply chain Advocating to emaned Hatch-Waxmen to limit brand companies from serially suing generic companies over the same molecule.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem